• Non ci sono risultati.

ACE activity 173

N/A
N/A
Protected

Academic year: 2021

Condividi "ACE activity 173"

Copied!
9
0
0

Testo completo

(1)

heavy chain 281, 296 239, 244 blockers 43

41, 288 346-347, 349, 351 2-oxoglutarate 26, 45

Abdominal aortic constriction 203, 283

ACE activity 173

ACE inhibitor 105, 107, 110, 280- 287, 289-291, 293, 298, 330 Achilles tendon 126

Acoustic impedance 117, 119, 125- 126, 136-137

AcSDKP 171-172, 282-283 Adenosine 85, 87-90, 344-345 Adenovirus 246, 345-346 Adenylyl cyclase 87, 89-90, 92 Adhesion 8, 62, 67, 201-202, 220, 276, 283, 285, 292, 313, 356 Adrenomedullin 94, 284

Advanced glycation end products 276

Adventitia 37, 42, 255

AGEs 276, 298-299

Aldosterone 27, 30-31, 42-43, 58, 167, 169, 172-175, 241, 277-284, 286, 288, 290-291, 294, 330-334 ALT-711 299

Amino-terminal propeptide 102, 104

Aminoguanidine 299-300 Amlodipine 59, 106 Aneurysms 41 ANF 318-319

Angiogenesis 35, 38, 40, 217, 244- 245, 248, 293

Angiotensin I 254, 268, 279 Angiotensin II 27, 30, 32, 39, 58, 90, 92-93, 241,253-254, 268, 278- 280, 282-283, 285-287, 290, 292- 293, 295-297, 330-331, 333, 359 Angiotensinogen 36, 93, 167, 172- 273, 279, 284, 294, 296

Anisotropic 17, 41, 119-122, 126 Antifibrotic 43, 45, 111, 277-279,

(2)

283, 285, 289, 292, 295, 334 Antioxidants 296

Antisense 335, 337

Aorta 172, 254-255, 295, 299, 311, 347

Aortic insufficiency 154

Aortic stenosis 30-31, 149, 151, 153 Aortic valve 155, 168, 265-266, 312 Aortocaval fistula 197-198, 200- 202/204

Apoptosis 37, 158-160, 171, 241, 244, 299, 318-319, 358

Apparent backscatter 118, 127, 131 Apparent frequency dependence 132-133

Apparent integrated backscatter 132 Arrhythmias 18, 72, 105, 174, 240, 276, 281

Arteriovenous fistula 360 Ascorbic acid 26

Aspirin 295

AT1 32, 39, 42-44, 70, 88, 93, 105- 106, 167, 171-175, 254, 266, 268, 279-280, 282-284, 286-287, 289, 293-294

AT2 32, 39, 42, 93, 171-172 Atherosclerosis 213, 275, 295 Atrial natriuretic peptide 204-205, 285

Atrial natriuretic factor 90, 94, 318 Attenuation 116-125, 127, 131, 175, 186, 245, 259-260, 282, 289, 292, 295

Attenuation coefficient 116-117, 123, 125

Autoradiography 71, 168, 171 AV shunt 253-256, 258-268 Average nadir 136

Average peak 136

Backscatter 116-120, 122, 127-138,

141-142

Backscatter coefficient 118-119, 127, 129-132, 134, 137

BAPN 41-42 Batimastat 297 Benezaprilat 282 Beraprost 282

Biopsy 131, 139, 141, 155, 225, 229

Bisoprolol 289 BIVADs 311

BK 27, 32, 44, 88, 90, 172, 174, 332

Bleomycin 292, 345 BNP 294

Bosentan 285

Bradykinin 27, 32, 44, 90, 93, 170- 172, 280, 282, 284, 286, 297, 330, 332, 344-345, 359

Brain natriuretic peptide 294

Calcineurin 280, 282-284

Captopril 134, 174, 280-281, 285 Carboxy-terminal propeptide 101- 103, 106-107, 140

Carboxypeptidase 199

Cardiac allograft rejection 139 Cardiac amyloidosis 139-140 Cardiac architecture 4 Cardiac contractility 225-286 Cardiac dysfunction 33, 221-224, 228-229, 247, 359

Cardiac fibroblasts 24-26, 29, 44, 57, 65-72, 83, 85-92, 155, 215, 218, 253, 280, 283, 288, 291, 293-294, 298, 344, 358

Cardiac pump 239

Cardiac stiffness 241, 276, 292, 299 Cardiomyocyte adhesion 201-202 Cardiomyopathic hearts 134 Cardiopulmonary bypass 220, 225,

(3)

229-231

Carvedilol 289-290 Catalase 356-357, 359

Catalytic domain 182-183, 213-214, 244

Catecholamine 27, 35, 84, 88, 169, 172, 333

Cathepsin G 199, 243 Cathepsin D 36, 172-173 Celiprolol 289

Cell Cycle 64-65, 172, 336-337 Cell death 158, 171, 297 cGMP 286

Chamber enlargement 31, 33 Chamber stiffness 141, 202, 290 Chemotaxis 62, 64-65, 67, 203, 283 Chronic inflammation 35, 294 Chymase 42-43, 197-199, 203, 205, 243

CIMP 355-361 CITP 103-106, 110

Coiled perimysial fibers 7, 11, 15 Collagen deposition 30, 34-35, 43, 60, 131, 133-134, 188, 239-241, 245-247, 266, 275-277, 280-282, 284-292, 294-296, 298-299, 301, 344

Collagen metabolism 8, 101, 103, 111, 293-294

Collagen volume fraction 30, 106- 107, 201, 267, 296

Compound 48/80 200 Concentric hypertrophic 30 Confocal microscope 11

Confocal microscopy 12, 16, 225- 226

Congestive heart failure 31, 33, 42, 110, 149, 151, 154, 157, 181, 200, 219, 285, 355-356

Connective tissue growth factor 26- 27, 39, 292

Connective tissue 3, 5-8, 11, 14-18,

25, 57-58, 167-168, 171-172 Corticosteroids 191, 243, 276, 287, 295

Creatine kinase 108-109 Cromolyn 202-203, 205

Cross-links 38-41, 45, 125, 276, 298-299

CTGF 26-27, 39, 44-45, 292 Cyclic AMP 83, 85-88, 90-94 Cyclic GMP 83, 89-92 Cyclosporine 175, 284

Cytokines 24, 26-27, 29, 32, 35, 38, 57-61, 63-65, 67-73, 84, 158, 160, 186, 191, 199, 205, 217, 223, 227- 228, 239, 241, 243, 246, 268, 276- 277, 289, 291, 293-298, 313, 315, 317, 358-359

Cytoskeleton 16

DCM 186-187, 189

Decompensated heart failure 59, 72, 314

DETA NONOate 286

Diabetes 138, 140, 279, 286, 297- 299, 301

Diabetic cardiomyopathy 344 Diastolic function 38, 43, 101, 141, 151, 281-282, 286, 295

Digitalis 110 Digitoxin 44

Dilated cardiomyopathy 31, 44, 59, 133-134, 141, 154, 157, 186, 190, 197-198, 200, 203, 219, 226, 267, 289, 318-319, 321, 324

Disintegrin metalloproteinases 70, 355

Diuretics 110

DOCA-salt hypertensive rats 278, 285, 292

DOCA-salt rat 280

Doppler echocardiography 141

(4)

Doppler measurements 139 Doxorubicin (Adriamycin) 132 Doxycycline 221, 225

Dystrophin 316, 318

E-selectin 285

Eccentric 31, 40, 154, 253, 265-266 ECG 323

Echocardiographic 107, 115, 121, 138-140, 321, 323,

Eicosanoids 87, 91, 280

Ejection fraction 72, 109, 155, 289, 321, 323

Elastic moduli 136

Elastin 3, 7, 24-25, 184, 299, 356- 358

Electron microscopy 5-6, 60, 224- 226

EMMPRIN 243-244

Enalapril 172, 174, 280-281, 285- 286, 297

Endocardial endothelial 355-356 Endocardium 4-6, 17, 133, 170 Endomyocardial biopsy 139, 141 Endomysium 6-8, 15-16, 29, 41 Endoproteinases 243

Endothelial cells 7-8, 23, 29, 84, 90, 170, 172, 174, 215, 220, 241, 284, 286-287, 355, 358, 360

Endothelin 27, 35-36, 44, 89, 171- 172, 220, 277, 279-280, 283, 285- 286, 289, 291-292, 295, 330-331, 333

Epicardial tangent plane 9, 346 Epicardium 5-6, 17, 133, 346 Epimysium 6, 8, 15-16, 41 ERK ½ 87, 89, 93-94, 296 94, 285-286 Etanercept 72, 205, 293-294

94, 285

E x t r a c e l l u l a r M a t r i x 243

MetalloPRoteinaseInducer

Fenofibrate 332 FG041 44, 288 Fiber angle 5, 14 Fibrinolysis 110, 246

Fibroblasts 8, 23-26, 29, 34, 36-38, 42, 44, 57-58, 61-62, 64-73, 83-92, 101, 155, 157, 167, 170-175, 191, 214-215, 218, 240-241, 246, 248, 253-254, 276-277, 280, 282-284, 286, 288, 290-294, 297-298, 329- 330, 334, 337, 339, 344-345 Fibronectin 3, 25, 40, 44, 69, 94, 183-184, 276, 290, 296, 334, 356- 357

Finite strains 348 Fluvastatin 295 Forskolin 87, 90

Free radical 294, 296, 299

24, 34, 85, 91-92 Galardin 245

Gene Therapy 46, 343-345 Glucocorticoids 27, 191 Glycosaminoglycans 24, 34 GM6001 245

Granulocytes 245-246

Halofuginone 333

Heart failure 8, 18, 23, 29-31, 33, 35, 40-43, 70, 72, 88, 109-110, 138, 149-151, 154-155, 157, 181-182, 185-186, 188-192, 197, 200-201, 205-206, 213, 218-219, 227, 239- 241, 247-248, 253-254, 266-268, 275-276, 279, 281-285, 289, 293- 298, 301, 311-315, 319, 321, 324, 329-330, 344, 355-356, 359-361

(5)

Heat-shock protein 241 Hemodynamic forces 239 Hemopexin l83, 213 HOE140 174, 282 Hydrochlorothiazide 281 Hydrogen peroxide 214, 226 Hydroxyproline 24, 26-27, 30, 34, 44-45, 129-133, 174, 256-257, 263, 280, 288

Hypertension 8, 18, 29, 31, 43, 88, 105-108, 138, 141, 149, 151, 168, 172, 188, 197, 203, 241,275,278- 281, 285-287, 289-290, 294, 299, 301,313,330,344

Hypertensive heart disease 101, 104, 111,278

ICAM-1 67, 285, 295 Icatibant 174

IGF-1 26, 294 IGF-2 26

IL-1 27, 35, 58-59, 61-62, 64-65, 67, 69-73

Ilomastat 245

Immunolabeling 170-171 In situ hybridization 167-169 In situ zymography 224 Indomethacin 282

Infarct expansion 34, 40, 110, 157- 159, 286

Inflammatory cells 34, 58, 67, 173, 240, 245-247, 294

iNOS 89-92, 94, 299 Insulin growth factor 26

Integrated backscatter 127-129, 131-136

Integrin 16, 44, 239, 356-357 Intercellular adhesion molecule-1 285

27, 58, 61, 64-65, 67, 69-71, 73

Interleukin-1 27, 58, 65, 73, 268 Interstitial 28, 30, 57, 59-60, 102, 149, 152, 157, 160, 168, 170, 172, 175, 181, 183-184, 187, 197-198, 200-201, 239-240, 257, 260, 266, 275-276, 280, 282, 284, 287, 295, 329

Interstitial fibrosis 29-30, 35-36, 45, 101, 105, 110, 133-134, 141, 173- 175, 279, 284, 290, 294-297, 313, 315, 358

Ischemia-reperfusion injury 213, 220

Ischemic heart disease 101, 108 Ischemic preconditioning 222

Kallikrein 243 Kininase 170-172

Krebs-Henseleit solution 130-131

L-arginine 286-287, 356-357 L-Mimosine 288

L-NAME 286-287

L-nitroarginine methylester 286 Labetalol 290

Lactic dehydrogenase 108

Laminar organization 9, 12-13, 17- 18

Laminin 3, 25, 40, 184, 296 Laparotomy 254

Law of LaPlace 150, 154

Left coronary artery 168-169, 279, 298

Left ventricular wall motion 3 Leukocytes 246-248, 287 LIF 291

Lipid peroxidation 299 Lisinopril 105, 107, 173, 281 Losartan 105-106, 171, 174, 255, 258-265, 268-269, 280, 284-285,

(6)

292

LVADs 311-313, 321 Lysyl oxidase 277, 288

M-mode 135

Macrophage activation 58

Macrophages 24, 36, 58, 167, 170, 172-173, 175, 246-247, 294 MAPK 87, 89-90, 93-94, 319 Mast cell degranulation 198, 202, 204-206

Mast cell maturation 203 Mast cells 197-200, 203-205 Matrixin fold 214

MCP-1 285

Mechanical loading 318

Mechanical unloading 41, 59, 313- 316,319-321

Methylprednisolone 295 Metoprolol 88, 289-290 Micromanometer 255

Migration 61-62, 67-68, 71, 93, 244-245, 276, 292

Mineralocorticoid 283-284

Mitogen-activated protein kinases 319

Mitral regurgitation 31, 155, 189, 197-198, 201

Mitral valve 172, 203, 265

MMP inhibitors 73, 186, 189, 217- 219, 221, 223-225, 228, 230, 240, 244-248, 291, 298

Monoclonal antibodies 7, 170, 343 Monocyte Chemotactic protein-1 285

Multivariate analysis 139 Muscle bundles 4, 42

Myocardial architecture 3, 14-15, 17, 133

Myocardial backscatter 128 Myocardial infarction 8, 17, 23, 31-

32, 39-40, 61, 72, 93, 108-109, 129, 133, 138-139, 149, 157, 160, 167, 181, 185, 189, 197-198, 203, 218- 219, 239-240, 243-246, 254, 267, 275-276, 278-280, 283-285, 288- 292, 295-296, 313, 329, 333, 336- 337, 344, 359, 361

Myocardial protection 222 Myocardial relaxation 286 Myocardial stress 150, 181 Myocardial stunning injury 220 Myocyte orientation 4, 8

Myocyte slippage 35, 42, 246, 297 Myofiber axis 5

Myofiber diameter 133

Myofibroblasts 26, 36, 38, 61, 170- 173, 175, 240-241, 246, 248, 254, 282, 291-292, 329, 338

NADPH 297, 356-357, 360

N-acetyl-seryl-aspartyl-lysyl- proline 172, 283

Necrosis 27, 158, 169-170-197, 241, 268, 277, 281, 287, 297, 315- 316

Nedocromil sodium 202 Neutrophils 35, 58, 110 Nifedipine 290

Nitrates 37, 43, 110

Nitric oxide 32, 44, 61, 89-90, 172, 216, 226-227, 286, 295, 330, 332, 345, 356

Normal strain 348 Nuclear 191

O-Phenanthroline 218, 221 Oligonucleotides 334-335 Omapatrilat 284

Osteopontin 280, 282

Oxidative stress 186, 214, 216-217,

(7)

223, 227-228, 285, 294-297, 299, 355-356, 358-361

Pacing 31, 186, 200, 205, 219, 245, 254, 267-268, 282, 290, 293, 359 PAI-1 246-247, 286-287

Papillary muscle 6-7, 15-16, 137, 298

Paracrine 32, 61, 70, 85, 87, 93, 167, 175, 241, 290, 330

Parathyroid hormone 27 Parenchymal cells 23, 58 PD166793 222, 227, 297 PD98059 332

PDGF 27, 62

Pericardium 38, 168-169, 173 Pericytes 24, 240

Perimysium 6-8, 15-16, 29, 41 Perindopril 174, 280

Perivascular fibrosis 101, 105, 110, 133, 175, 282-283, 286, 290, 295 Peroxynitrite 214, 216-217, 223, 226-228, 230

Phosphodiesterases 85

Phosphorylation 65, 89, 94, 283, 319, 333

Picrosirius11, 106, 168 PIIIP 104, 107-110 PIP 103-110, 140-141 Pirfenidone 292

Plasmin 109-110, 214, 243-244, 246, 298, 345

Plasminogen activator inhibitor-1 246, 286

Platelet aggregation 220, 286 Platelet derived growth factor 27, 62, 70, 268

Polymorphonuclear cells 29 Preconditioning 222 Probucol 296

Procollagen 25, 27, 34, 42, 101-

104, 106-107, 140, 241, 276, 284, 287-288

Proinflammatory cytokines 60, 72, 295-296, 313

Proline 24-26, 30, 44, 69, 172, 276, 283, 288

Proly-4-hydroxylase 26-27, 44, 287-288

Propeptide domain 182-183, 213- 217, 228, 244

Prostacyclin 282

Prostaglandins 61, 65, 88, 172, 284, 330, 332, 359

Proteoglycans 3, 25, 184, 239 Proteolytic activity 29, 183, 187- 189, 224, 243, 256

Purkinje fiber 18 Pyridinoline 103

Quinapril 105, 172

RAAS 30-31, 173-175, 329 Radioimmunoassays 101, 105 Ramipril 281, 298

Rapid ventricular pacing 31, 219 Reactive fibrosis 241, 275, 282, 329, 332

Receptor tyrosine kinases 318 Receptors 17, 36, 42, 59, 70, 72, 83, 85, 87-91, 93-95, 168, 171-173, 239, 241-242, 277, 279-280, 282, 284-287, 289, 291-294, 298, 329- 330, 332-333, 345

Regional deformation 3 Regurgitant valve disease 149 Remodeling strain 348, 350-351 Reparative fibrosis 35, 275 Restenosis 333, 335 RTK 316, 318-319 RVADs 311

(8)

Sarcomeric muscle actin 36

Scar 35-38, 40-41, 43-44, 58, 61, 93, 168-171, 173, 190, 240-241, 245,247-248, 291, 296

Scar contraction 36-37, 241 Scar formation 35, 37, 42, 109, 174, 275, 279, 345, 71

SERCA2a 319-320 Serine proteinases 359

Serological markers 42, 101, 111 Shear deformations 17

Shear strains 348 Shearing 3, 17

SHR 30, 43, 105-106, 108, 179, 188, 278-279, 281, 283-284, 286, 290-291, 293-294

Slippage 3, 35, 42, 190, 246, 297 Smad 291, 333

Smad2 283, 291-292

Smooth muscle cells 8, 23, 26, 84, 93, 167, 215, 218, 285-286, 288, 290, 336, 338, 358

Sonomicrometry 157

Spironolactone 42, 110, 280-281, 284, 331-332, 340

Spontaneously hypertensive rat 30, 106, 175, 188

Sprague Dawley rats 299 Streptokinase 45, 109

Streptozotocin 284, 292, 297, 299 Stromelysin 28, 183-184, 197, 199, 213, 243, 244, 276, 355

Superoxide 216, 227, 297, 356-357 Superoxide anion 214, 226, 295, 297

Superoxide dismutase 356, 359 Syrian hamster 134, 200, 292 Systolic failure 149

Systolic wall stress 151

Telopeptides 102-103 Tetracycline 218, 231, 245 Thalidomide 293

Three-dimensional strain 17 Thrombin 88, 243, 333, 344 Thrombolysis 109

Thrombolytics 220 Thromboxane 295 Tight-skin mice 133

TIMP-435, 185, 188, 215, 217-218, 223-224, 226, 228, 298, 355, 358 Tissue plasminogen activator 109, 345

Titin 16

27,35, 58-65, 67, 69-73, 90, 191, 197-199, 202, 204-206, 241, 245-246, 277, 289, 291, 293, 295, 297, 315-319

Tranilast 203, 292

Transfer function 127-128

Transforming growth 26, 58, 70, 191

Tropomyosin 226 Troponin I 223, 225 Trypsin 214

Tryptase 197, 199, 203, 205 Tryptase Chymase and 198 Tumor necrosis 27, 58, 90, 158, 197, 241, 268, 315

Type I carboxy-terminal propeptide 103, 106-107

Type III collagen 7-8, 201, 335 Type III amino-terminal propeptide 104

Ultrasonic beam 118-120 Ultrasonic velocity 116, 125-126 Ultrasonic waves 115-116, 118 Ultrasound 115, 118, 120, 124, 126, 131, 142

Univariate analysis 139

(9)

Valve leaflets 167-168, 170, 172, 175, 280

Valvular heart disease 149-150 Vascular adhesion molecule-1 285 Vascular endothelial growth factor 217, 344

VCAM-1 285 VEGF 344

Ventricular assist devices 59, 219, 311

Ventricular dysfunction 109, 189, 219, 275-276, 295-296, 329-330 Ventricular mechanics 97-150, 152, 155

Ventricular remodeling 38,73,149- 150, 152, 157, 160, 197-200, 202- 206, 218, 245, 254, 266-267, 269 Vimentin 40, 171

Viscoelasticity 119, 240 Vitamin C 26

Vitamin E 296-297

Volume overload 31, 57, 149, 154- 155, 160, 188-189, 197-198, 201- 206, 253, 255, 260, 264-269, 361

Wall stress 37-38, 40, 150-152, 154, 181, 186, 188,245,266 Wall tension 37, 154, 156

Wound healing 57-58, 61-62, 72, 182, 184, 213, 240-241, 244-248, 291

Wound repair 276

Zofenopril 290 Zymogens 183 Zymograms 256, 261

Riferimenti

Documenti correlati

- di autorizzare la stipula del contratto per la fornitura di n. 51 lettini da visita per gli ambulatori medici delle sedi INAIL della Puglia e di n. 1 lettino da visita elettrico

Nel dichiarare infondata la questione dell’illegittimità della sospensione del processo con messa alla prova – in quanto “pena senza condanna” applicata in violazione

Gabriele Bassi – Tecnico Regionale per l’Impiantistica Sportiva - gli elaborati progettuali allegati, che prevedono la realizzazione di un “Impianto sportivo permanente

in data 6 luglio 2020 il Direttore della Direzione Pianificazione Generale del Dipartimento Programmazione e Attuazione Urbanistica ha espresso il parere che di seguito

The entire appendix is wrapped within the caecum until only a sufficient length is left to bring it out through the abdominal wall when the stoma is constructed.. The antimesen-

[r]

As a result, radio- labeled amino acid imaging could allow for a better discrimination between tumor tissue and inflammatory tissue and thus also in a more appropriate tumor vol-

• Angiotensin-converting enzyme (ACE) inhibitors have been shown in large randomized controlled trials (RCTs) to prevent cardiovascular disease (CVD) outcomes significantly in